WASHINGTON - In a move that puts him in the running for BioCentury's first annual Washington Chutzpah award, Sen. Edward Kennedy last week sent mailings to biotech CEOs thanking them for their help in enacting FDA reform legislation.

Kennedy (D-Mass.), who filibustered against S. 830 twice and was one of two members of the upper house to vote against the Senate version, wrote to biotech and pharmaceutical executives: